Noel Wardle writes for Pharmacy Business on the balancing act of medicine supply
Noel Wardle has written for Pharmacy Business on the balancing act of medicine supply. Read more below.
Our thinking
Becky Lawton
Becky Lawton and Francesca Charlton write for P3 Pharmacy on employment issues for pharmacies in light of the Omicron variant
What can owners and managers do if staff refuse to comply with latest restrictions?
Melania Constable
Melania Constable and Georgina O'Sullivan write for P3 Pharmacy on the easing of Covid winding up restrictions
Regulations mean that a creditor can once again rely on an unpaid statutory demand to apply to the court for a winding-up petition.
Ben Moore
Playing fast and loose with justice: estoppel by conduct
Ben and Simon look at La Micro Group (UK) Ltd and another v La Micro Group Inc and others and its impact on estoppel
Georgina O'Sullivan
Amelia Goodwin and Georgina O'Sullivan write for P3 Pharmacy on the key to managing performance
Day-to-day management is time consuming enough, so if you have a workforce with no apparent issues, performance may not be on your radar.
Tim Jenkins
Pharmacy Brief - September 2021
The September edition of our Pharmacy Brief
Noel Wardle writes for P3 Pharmacy on whether pharmacies have to provide medicines in compliance aids
Do pharmacies have to provide medicines in compliance aids, and can they can charge for them?
Lauren Kelly
Jennifer Berritt and Lauren Kelly write for P3 Pharmacy on The Lease Code and looking for better lease terms
The Lease Code published by The Royal Institution of Chartered Surveyors took effect on 1 September 2020.
Rory Partridge
Weighing in on the importance of attention to detail in service cases
Rory looks at recent judgments that have emphasised the need to follow correct procedure when serving documents in court cases
Noel Wardle wrote for Chemist & Druggist on the implications of the new Health and Care Bill mean for community pharmacy
The government has now published its proposed overhaul of health and care in England.
Tim Jenkins
Charles Russell Speechlys advises Avicenna Group on duo of pharmacy group acquisitions
The acquisition takes Avicenna to a total of 135 pharmacy branches.
Pharmacy Brief - June 2021
The June edition of our Pharmacy Brief
Samuel Milne
Sam Milne writes for Pharmacy Business on the process of selling a pharmacy
Sam Milne outlines the process in making that all important decision to sell a pharmacy.
Noel Wardle quoted by Chemist and Druggist on how to make hub-and-spoke work for all independent pharmacies
Noel considers whether patients would be for or against their prescription being assembled at a hub, rather than a pharmacy.
Rachel Warren
Property Patter: Navigating the complexities of Pharmacy Property
Pharmacy property is a specialist area which contains many traps for the unwary.
Sonia Kenawy
Adding claimants pre-service and amending outside the limitation period: pitfalls for the unwary
Sonia looks at a recent High Court judgment and its important guidance on the ability of claimants to be added to a claim before service
Georgina O'Sullivan
Amelia Goodwin and Georgina O'Sullivan write for Pharmacy Business on managing employee performance
Why contractors should prioritise performance management of employees as a regular feature of their business strategy.
Joe Edwards
Damages-based agreements: an island of clarity in changing seas
Simon, Joe and Lauren look at a recent judgment which is a welcome island of clarity in the damages-based agreement sea of uncertainty.
Pharmacy Brief - March 2021
The March edition of our Pharmacy Brief
Natalie Deuchar
Natalie Deuchar and Leonora Owens write for Pharmacy Business on the considerations to take into account when pharmacists look to obtain a new unit
Pharmacists should be aware of the law when considering obtaining a new unit.
Noel Wardle quoted by Chemist and Druggist on the issues that need to be considered before pharmacies adopt a hub-and-spoke dispensing model
Under current legislation, the hub-and-spoke model can be carried out by pharmacies owned by the same legal entity.